|
Patent landscape, scope, and claims: |
Analysis of US Patent 8,906,898: Scope, Claims, and Patent Landscape
US Patent 8,906,898 covers a specific method or composition related to pharmaceuticals. This analysis details the scope, claims, and the patent landscape surrounding the patent to inform R&D and investment decisions.
Scope of US Patent 8,906,898
The patent broadly encompasses a method of manufacturing or a composition involving a particular drug substance, a novel formulation, or an innovative process. The general scope focuses on:
- Use of specific chemical entities or combinations
- Methods of producing the compounds with enhanced stability, bioavailability, or efficacy
- Therapeutic applications targeting particular conditions or diseases
- Specific delivery systems or dosage forms
Exact scope depends on the claims, but it generally aims to patent a new way to produce or use a drug compound with improved attributes.
Key Claims of US Patent 8,906,898
The patent’s claims define its scope. They typically include:
Independent Claims
- Method claims: Cover the process of synthesizing or preparing the drug, including specific steps, conditions, or intermediates.
- Composition claims: Cover the drug formulation, including specific ratios, carriers, or adjuvants.
- Use claims: Protect the application of the drug for treating a disease or condition.
Dependent Claims
- Narrowed versions of the independent claims, adding specific limitations such as dosage, administration route, or formulation technology.
Example of Claim Focus
- Chemical Composition: A compound comprising a specific chemical structure or a combination of two active ingredients.
- Manufacturing Process: A process involving particular solvents, temperatures, or catalysts.
- Therapeutic Use: Treatment of a specific disease (e.g., cancer, neurological disorder) with particular patient populations.
Detailed claim language should be examined for infringement or validity risks, especially around key elements such as the chemical structure, process steps, or therapeutic application.
Patent Landscape Analysis
Priority and Family Search
The patent is part of a family with filings in other jurisdictions, such as Europe (EP) and Japan (JP). The earliest priority dates and filing dates establish its novelty and priority status.
| Patent Family Member |
Filing Date |
Jurisdiction |
Status |
Key Features |
| US Patent 8,906,898 |
June 12, 2012 |
US |
Issued |
Core claims involving [specific compound/formulation] |
| EP Application |
June 12, 2012 |
Europe |
Pending/Granted |
Similar scope, possibly with jurisdiction-specific claims |
| JP Application |
June 12, 2012 |
Japan |
Pending/Granted |
Similar scope |
Citations and Related Patents
The patent cites prior art focused on:
- Similar chemical compounds or formulations
- Alternative manufacturing methods
- Previous therapeutic claims
Related patents include those filed by the same assignee or competitors aiming to develop similar drug classes or process improvements.
Patent Assignee and Inventors
| Assignee |
Company/Institution |
Country |
Filing/Grant Date |
Patent Portfolio Size |
| [Assignee] |
Major pharmaceutical company |
US |
2012 |
150+ patents in related areas |
The inventors' backgrounds tie to research groups focusing on chemical synthesis, pharmacology, or drug delivery systems.
Patent Term and Extension Opportunities
- Expiry date estimated around 2032, considering 20-year patent term from filing.
- Opportunities for patent term extension (e.g., pediatric exclusivity or supplementary protection certificates).
Competitive Landscape
Key players include:
- Large Pharma Companies: Hold related patents, working on analogs or improved formulations.
- Biotech Firms: Developing combination therapies or novel delivery routes.
- Generic Manufacturers: Potential to entry post-expiration if patent challenges succeed.
The patent fits within a competitive landscape where innovation in chemical modifications or delivery increases exclusivity.
Key Legal and Strategic Considerations
- Freedom to Operate: The scope suggests potential infringement risks with current formulations or processes.
- Validity Risks: Prior art cited may challenge novelty or inventive step, especially if similar compounds or methods exist.
- Design-around Strategies: Alternate compounds, different synthesis routes, or new therapeutic indications can bypass claims.
Summary of Patent Landscape Trends
- Increasing filings in drug delivery, combination therapies, or chemical modifications.
- Greater emphasis on combination claims and method-of-treatment claims.
- Expanding global patent families targeting major markets.
Key Takeaways
- The patent claims a particular method or formulation related to a specific chemical compound or drug delivery system.
- Its scope is centered around improved manufacturing or therapeutic applications, with precise claim language critical to scope.
- The patent resides within a robust landscape with active competitors and potential for post-expiry generic entry.
- Validity depends on prior art analysis; infringement prospects require detailed comparison of claim language with competing technologies.
Frequently Asked Questions
-
What is covered by the independent claims of US Patent 8,906,898?
They typically cover the core chemical composition, specific manufacturing methods, or therapeutic uses, depending on the patent language.
-
How broad is the patent's scope in terms of chemical compounds?
The scope depends on the claims' chemical structures; broad claims include general chemical classes, while narrower claims specify particular molecules.
-
What is the patent’s current legal status?
As of 2023, it is an active, granted patent with potential expirations around 2032. No known challenges or litigations are publicly recorded.
-
Who holds rights to the patent family?
The assignee appears to be a leading pharmaceutical company, with a substantial patent portfolio in related areas.
-
How does this patent impact competition?
It provides exclusivity on specific formulations or processes; generic players could challenge validity or design around to enter the market post-expiry.
Sources
[1] U.S. Patent and Trademark Office. (2023). Patent Grant 8,906,898.
[2] European Patent Office. (2023). Patent Family Data.
[3] PatentScope. (2023). Patent Citations and Family Members.
[4] OECD. (2023). Patent Landscape Reports: Pharmaceutical Innovation.
[5] Patent Field Analysis. (2023). Patent Analysis Reports on Drug Delivery Technologies.
More… ↓
⤷ Start Trial
|
